Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Nature Immunology|January 18, 2006
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9Koichi Tabeta, Kasper Hoebe, Edith M Janssen, et al.Proceedings of the National Academy of Sciences of the United States of America|March 4, 2003
Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouseTim Wiltshire, Mathew T Pletcher, Serge Batalov, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 3, 2007
A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell functionMartin Schwander, Anna Sczaniecka, Nicolas Grillet, et al.Psychopharmacology|September 15, 2025
Behavioral variation across multiple phases of intravenous cocaine self-administration among genetically diverse mouse populationsPrice E Dickson, Udita Datta, Troy D Wilcox, et al.Journal of Medicinal Chemistry|February 17, 2006
Hybrid antibacterials. DNA polymerase-topoisomerase inhibitorsChengxin Zhi, Zheng-Yu Long, Andrzej Manikowski, et al.Gut Microbes|November 18, 2022
Reproducible changes in the anorexia nervosa gut microbiota following inpatient therapy remain distinct from non-eating disorder controlsFarnaz Fouladi, Emily C Bulik-Sullivan, Elaine M Glenny, et al.Biorxiv : the Preprint Server for Biology|January 9, 2026
A shared genetic regulator of metabolism and addiction-related behavior in mice and humansJason A Bubier, Michael C Saul, Heidi S Fisher, et al.Neuroscience and Biobehavioral Reviews|January 23, 2018
Reproducibility and replicability of rodent phenotyping in preclinical studiesNeri Kafkafi, Joseph Agassi, Elissa J Chesler, et al.Psychopharmacology|January 4, 2020
Characterization of genetically complex Collaborative Cross mouse strains that model divergent locomotor activating and reinforcing properties of cocaineSarah A Schoenrock, Padam Kumar, Alexander Gómez-A, et al.Journal of Medicinal Chemistry|July 10, 2023
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279Silvana Leit, Jeremy Greenwood, Samantha Carriero, et al.Pageof 11